Intersect ENT Competitors and Similar CompaniesClear all

Intersect ENT's competitors and similar companies include OptiNose.
Intersect ENT
Intersect ENT
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
OptiNose
OptiNose
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
Founding Date
Founding Date
2003
Founding Date
2000
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Morrisville, US HQ
Oslo, NO
Swindon, GB
Employees
Employees
4337% increase
Employees
2048% decrease

Financial

Revenue (est.)
Revenue (est.)
$106.7m (FY, 2021)
Revenue (est.)
$78.2m (FY, 2024)
Cost of goods
Cost of goods
$30m (FY, 2021)
Cost of goods
$7.2m (FY, 2024)
Gross profit
Gross profit
$76.7m (FY, 2021)
Gross profit
$71m (FY, 2024)
Net income
Net income
($159.6m) (FY, 2021)
Net income
($21.5m) (FY, 2024)

Operating

Patents (US)
Patents (US)
30 (FY, 2016)
Patents (US)
43 (Jun, 2017)
Trademarks (US)
Trademarks (US)
4 (FY, 2016)
Trademarks (US)
3 (Jun, 2017)

Funding

Total funding raised
Total funding raised
$ 102.9m
Total funding raised
$ 120.5m
For sources of this data, please see the company profile

View Company Profiles

OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.

View company